Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

Michael O'Riordan

July 27, 2021

News Daily News

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

L.A. McKeown

January 11, 2021

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Race and Gender Bias May Sway Decisions in Advanced HF Care

L.A. McKeown

July 21, 2020

News Daily News

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Michael O'Riordan

March 20, 2020

News Daily News

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

Todd Neale

January 29, 2019

News Daily News

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Michael O'Riordan

February 02, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

Societies Offer Guidance on Clinical Utility of Circulatory Assist Devices

L.A. McKeown

April 29, 2015

Advertisement

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Acute HF Patients Live Longer When Seen by Specialists

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study

ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Race and Gender Bias May Sway Decisions in Advanced HF Care

New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals

Go With NOACs Over Warfarin in Most Cases: Updated A-fib Guidelines

No Cardiovascular Benefit With Omega-3 Fatty Acid Supplements: Meta-analysis

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Societies Offer Guidance on Clinical Utility of Circulatory Assist Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content